Not for biotech. The stocks in this segment are very sensitive to trial outcomes and drug efficacy
Stocks in biotech also very sensitive to coordinated naked shorting and cellar boxing by hedge funds.
alt Hacker News
Stocks in biotech also very sensitive to coordinated naked shorting and cellar boxing by hedge funds.